Skip to main content
Clinical Trials/CTRI/2021/03/032273
CTRI/2021/03/032273CompletedPhase 4

Effect of lignocaine on postoperative serum lactate dehydrogenase and lactate levels in patients underegoing bowel surgery

Government medical college and hospital Chandigarh0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.ASA (American Society of Anesthesiologists) grade I-II patients
  • •2.Patients scheduled to undergo restoration of bowel continuity

Exclusion Criteria

  • •1.Cardiac conduction abnormalities and congestive heart failure
  • •2.Renal or hepatic impairment
  • •3.Neurological disorders
  • •4.Pregnant and lactating women
  • •5.Patients not able to understand VAS
  • •6.History of substance abuse
  • •7.Contraindications to study drugs: lignocaine, paracetamol ,tramadol and diclofenac
  • •8.Chronic pain conditions, neurodegenerative or autoimmune disorders.

Investigators

Sponsor
Government medical college and hospital Chandigarh

Similar Trials